Type I receptors for PACAP (a neuropeptide even more important than VIP?).
about
Astressin-amide and astressin-acid are structurally different in dimethylsulfoxideMutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC(2): role of basic residues in the second transmembrane helixMolecular cloning of a novel variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor that stimulates calcium influx by activation of L-type calcium channelsThe immunomodulatory factors of bloodfeeding arthropod saliva.Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. Evidence for dual coupling to adenylate cyclase and phospholipase C.Effect of vasoactive intestinal peptide (VIP)-related peptides on cholinergic neurogenic and direct mucus secretion in ferret trachea in vitro.Pituitary adenylate-cyclase-activating polypeptide (PACAP) binding sites and PACAP/vasoactive intestinal polypeptide receptor expression in human pituitary adenomasDistribution and effects of pituitary adenylate cyclase activating peptide in cat and human lower oesophageal sphincter.Pituitary adenylate cyclase-activating polypeptide is an autocrine inhibitor of mitosis in cultured cortical precursor cells.Experimental study on vasoactive intestinal peptide (VIP) and its diaminopropane bound (VIP-DAP) analog in solution.Regulation of basal tone, relaxation and contraction of the lower oesophageal sphincter. Relevance to drug discovery for oesophageal disorders.The PACAP-type I receptor agonist maxadilan from sand fly saliva protects mice against lethal endotoxemia by a mechanism partially dependent on IL-10.Vasoactive intestinal peptide enhances TNF-α-induced IL-6 and IL-8 synthesis in human proximal renal tubular epithelial cells by NF-κB-dependent mechanism.cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.Peptide signaling paths related to intoxication, memory and addiction.Peptides as neurotransmitters in vascular autonomic neurons.Differential effects of peptide histidine isoleucine (PHI) and related peptides on stimulation and suppression of neuroblastoma cell proliferation. A novel VIP-independent action of PHI via MAP kinase.Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum.Pituitary adenylate cyclase-activating polypeptide induces expression of corticosteroid-binding globulin in cultured fetal hepatocytes: synergy with tri-iodothyronine.Comparative effects of PACAP and VIP on pancreatic endocrine secretions and vascular resistance in rat.PACAP(6-38) is a PACAP receptor antagonist for breast cancer cells.The pituitary adenylate cyclase activating polypeptide type 1 receptor (PAC1-R) is expressed on gastric ECL cells: evidence by immunocytochemistry and RT-PCR.Pacap stimulation of gonadotropin-II secretion in goldfish pituitary cells: mechanisms of action and interaction with gonadotropin releasing hormone signalling.Role of endogenous PACAP in catecholamine secretion from the rat adrenal gland.Embryonic expression of pituitary adenylyl cyclase-activating polypeptide and its selective type I receptor gene in the frog Xenopus laevis neural tube.Pituitary adenylate cyclase-activating polypeptide induces testicular testosterone synthesis through PGE(2) mediation in crested newt, Triturus carnifex.VPAC receptor modulation of neuroexcitability in intracardiac neurons: dependence on intracellular calcium mobilization and synergistic enhancement by PAC1 receptor activation.Genomic organization of the rat pituitary adenylate cyclase-activating polypeptide receptor gene. Alternative splicing within the 5'-untranslated region.Autoradiographic visualization of the receptor subclasses for vasoactive intestinal polypeptide (VIP) in rat brain.Is there appetite after GLP-1 and PACAP?PACAP/PAC1 autocrine system promotes proliferation and astrogenesis in neural progenitor cells.Opposing mitogenic regulation by PACAP in sympathetic and cerebral cortical precursors correlates with differential expression of PACAP receptor (PAC1-R) isoforms.Pituitary adenylate cyclase-activating peptide affects homeostatic sleep regulation in healthy young men.PACAP increases the cytosolic Ca2+ concentration and stimulates somatodendritic vasopressin release in rat supraoptic neurons.Long-term enhancement of REM sleep by the pituitary adenylyl cyclase-activating polypeptide (PACAP) in the pontine reticular formation of the rat.Facilitatory effects of pituitary adenylate cyclase activating polypeptide (PACAP) on neurons in the magnocellular portion of the rat hypothalamic paraventricular nucleus (PVN) in vitro.Mice with Markedly Reduced PACAP (PAC1) Receptor Expression by Targeted Deletion of the Signal Peptide
P2860
Q27646895-2990C5F4-1D56-4BFB-B44E-F7083490225CQ28345755-3D5AFB9D-C651-4B64-8DB6-06D957FECB0EQ28582265-B6340E11-A5A1-48F4-BE9A-16644565657CQ33962295-39C5F980-879D-47F3-9E43-2AB64ACB50FAQ34384700-6B3A21B2-1DC9-4B4E-8A0B-E8851BBAB0C1Q35041715-3A4C49AA-FEC3-44B6-A204-E2E129B77A1EQ35786043-313B9B86-CCDE-461A-A71E-ED3EA7EDB1BEQ35873161-FBC1D5BC-C961-4FAC-A1E1-65FF8336990FQ36085551-39283C7F-ADB8-4F76-B4C7-2A5B3C530002Q36873919-D0C2645A-F65E-47EF-A28D-B86720441F38Q36997708-3032C746-39A9-427F-A1DE-F21D6F2E63A3Q38918906-315CC9B1-734D-4664-A69A-4DB6FDA401B5Q39420647-E588D779-1CB9-495E-A195-02CB0D669118Q39842814-87E2C7AB-AB50-470D-98F5-D655F3E6BF7CQ40759051-B8242043-0979-4306-BF73-A4C03C8BAA7DQ40965120-8DAF2B96-C39E-4368-96B0-00ED8B899FCFQ41022560-92B735B0-4A30-4294-9890-8515081E0534Q42056620-8EB19B1F-30DA-4F43-85B7-AC0275574B12Q42108986-A626DFBC-FEEA-44A7-94C7-47E0EA918C7FQ42705991-04A9ABC3-017F-4A22-9E9C-4A5840F2FDE1Q42808312-EFEE0286-7C77-42E0-8BA5-C7FA290EEAC5Q42820101-8573852A-573A-44E4-A2AF-3855ABE0ADA7Q43644929-26D57E46-7526-4B82-BE19-DC31FA17F78AQ43771199-58A8A840-ED6D-484D-92C8-3FF69D7AE145Q43824634-17AE28C8-C56D-49D6-8B25-10943CC14802Q44062927-6EB949F6-C8A5-49BF-A851-D6B89C69845AQ44997656-38DB75D3-8983-4884-AD20-B3A6E3BE1B09Q48049943-3A117F9D-8174-4749-84DA-884C984EDAEDQ48295110-DA084633-38A1-4787-83E9-80161316E929Q48295125-D2451E22-4F2B-4F12-B88A-66E5050C6F60Q48364417-865CA77F-1F5D-4ADE-A73C-89646DECEDEFQ48386547-FFA4D076-F546-4E1A-B42C-9A43C91D3E5CQ48484596-8B64A49D-C35E-4730-AAD0-31D5DF02CCF2Q48506842-63262111-E76C-450D-9A5F-6B8EC2B156FDQ48737652-99E0418E-3D5C-40CD-ADF1-4A5C3887A9E2Q49127391-3C02400F-D1A3-4328-ADB7-E4C0E2051FA9Q57174520-EF78B73A-872D-470C-B064-565FB71E2871
P2860
Type I receptors for PACAP (a neuropeptide even more important than VIP?).
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Type I receptors for PACAP (a neuropeptide even more important than VIP?).
@en
type
label
Type I receptors for PACAP (a neuropeptide even more important than VIP?).
@en
prefLabel
Type I receptors for PACAP (a neuropeptide even more important than VIP?).
@en
P1476
Type I receptors for PACAP (a neuropeptide even more important than VIP?).
@en
P2093
J Christophe
P304
P356
10.1016/0304-4157(93)90011-C
P577
1993-10-01T00:00:00Z